Tfo Tdc, LLC United Therapeutics Corp Transaction History

Tfo Tdc, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$210.76 - $249.51 $530,693 - $628,266	-2,518 Reduced 99.92%	2 $0
Q4 2023 Feb 12, 2024	BUY	$214.88 - $256.94 $541,067 - $646,974	2,518 Added 125900.0%	2,520 $554,000
Q1 2023 May 03, 2023	SELL	$212.99 - $276.17 $13,205 - $17,122	-62 Reduced 96.88%	2 $0
Q4 2022 Feb 03, 2023	BUY	$205.95 - $280.43 $13,180 - $17,947	64 New	64 $17,000

681

42.2M

194K

298K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.